Disease stratification in idiopathic pulmonary fibrosis: the dawn of a new era?
Author:
Open Access
- 30 April 2014
- journal article
- editorial
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 43 (5) , 1233-1236
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9BMC Cancer, 2013
- Application of ’omics technologies to biomarker discovery in inflammatory lung diseasesEuropean Respiratory Journal, 2013
- Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug ResistanceClinical Pharmacology & Therapeutics, 2012
- Idiopathic Pulmonary Fibrosis: Pathobiology of Novel Approaches to TreatmentClinics in Chest Medicine, 2012
- Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective studyEuropean Respiratory Journal, 2012
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutationNew England Journal of Medicine, 2011
- Lebrikizumab Treatment in Adults with AsthmaNew England Journal of Medicine, 2011
- MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary FibrosisPLOS Medicine, 2008
- Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?European Respiratory Journal, 2007
- Outcomes and markers in the assessment of chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2006